Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

PPH vs. IYH: Which Healthcare Fund Is the Better Buy?

PPH concentrates on just 26 drugmakers, while IYH diversifies more broadly across 100 healthcare holdings.

PPH vs. IYH: Which Healthcare Fund Is the Better Buy?

Published August 18, 2026 · Category: Finance

Overview

Investors looking at the VanEck Pharmaceutical ETF (NASDAQ:PPH) and the iShares U.S. Healthcare ETF (NYSEMKT:IYH) are really deciding between a concentrated bet on drugmakers and broad exposure to the entire domestic medical ecosystem.

Both funds provide exposure to the defensive healthcare sector. But while PPH focuses strictly on pharmaceutical giants, IYH casts a wider net, including medical device manufacturers, service providers, and biotechnology firms.

Details

Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-year return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.